Five Prime Therapeutics, Inc. Retained Earnings
Five Prime Therapeutics, Inc. had Retained Earnings of -$516.21 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-03-22
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$516.21M.
- 2020-09-30: Retained Earnings (Accumulated Deficit) -$495.36M.
- 2020-06-30: Retained Earnings (Accumulated Deficit) -$468.94M.
- 2020-03-31: Retained Earnings (Accumulated Deficit) -$452.00M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2020-12-31 | -$516.21M 10-K · filed 2021-03-22 |
| 2020-09-30 | -$495.36M 10-Q · filed 2020-11-03 |
| 2020-06-30 | -$468.94M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$452.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$431.88M 10-K · filed 2021-03-22 |
| 2019-09-30 | -$400.53M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$364.46M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$330.07M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$294.68M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$255.93M 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$208.68M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$174.62M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$155.61M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$126.40M 10-Q · filed 2017-11-06 |
| 2017-06-30 | -$83.11M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$38.83M 10-Q · filed 2017-05-05 |
| 2016-12-31 | -$5.05M 10-K · filed 2018-02-27 |
| 2016-09-30 | $15.06M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $34.47M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $47.61M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $60.65M 10-K · filed 2017-02-24 |
| 2015-09-30 | -$235.48M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$211.51M 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$200.03M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$189.00M 10-K · filed 2016-03-11 |
| 2014-09-30 | -$177.17M 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$170.08M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$160.22M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$151.57M 10-K · filed 2015-03-18 |
| 2013-09-30 | -$144.26M 10-Q · filed 2013-11-13 |
| 2012-12-31 | -$122.70M 10-K · filed 2014-03-26 |